Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $472.1100 (0.92%) ($461.3225 - $475.9500) on Wed. Mar. 18, 2015. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.95% (three month average) | RSI | 74 | Latest Price | $472.1100(0.92%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 2.2% a day on average for past five trading days. | Weekly Trend | REGN advances 4.2% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(47%) XLV(38%) XBI(37%) QQQ(31%) SPY(29%) | Factors Impacting REGN price | REGN will decline at least -0.975% in a week (0% probabilities). VIXM(-12%) TLT(-6%) UUP(-2%) SHY(-2%) IGOV(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.975% (StdDev 1.95%) | Hourly BBV | 0 () | Intraday Trend | 1.5% | | | |
|
5 Day Moving Average | $449.24(5.09%) | 10 Day Moving Average | $438.09(7.77%) | 20 Day Moving Average | $429.07(10.03%) | To recent high | 0% | To recent low | 19.8% | Market Cap | $50.057b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |